Cat. No.: X24-09-YM1204
Fidaxomicin, Purity ≥98%
Synonym: 873857-62-6; Tiacumicin B; Dificid; Dificlir; Lipiarmicin; Lipiarmycin; OPT-80; Difimicin; Clostomicin B1; R-Tiacumicin B; Lipiarmycin A 3; PAR-101; Lipiarrmycin; [(2R,3S,4S,5S,6R)-6-[[(3E,5E,8S,9E,11S,12R,13E,15E,18S)-12-[(2R,3S,4R,5S)-3,4-Dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)oxan-2-yl]oxy-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy]-4-hydroxy-5-methoxy-2-methyloxan-3-yl] 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate
- CAS Number: 873857-62-6
- Compound CID: 10034073
Product Size
1 mg; 2 mg; 5 mg; 10 mg
Properties
Description
Fidaxomicin, soluble in DMSO and insoluble in water and ethanol, is the major analog of a family of macrocyclic lactones isolated independently by three different groups from cultures belonging to three different genera. The molecular weight of the compound is 1058.04, and its molecular formula is C52H74Cl2O18.
Molecular Formula
C52H74Cl2O18
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Solubility
In vitro: DMSO: 92 mg/mL (86.95 mM); Water: insoluble; Ethanol: insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Fidaxomicin can be studied extensively for its potential therapeutic applications in the treatment of Clostridium difficile infections (CDI).
Related Products
